Evidence map›Paper›PMID 30997729›Full record

ArticleJournal of applied clinical medical physics2019

Impact of treatment planning using a structure block function on the target and organ doses related to patient movement in cervical esophageal cancer: A phantom study.

Hidetoshi Shimizu, Koji Sasaki, Makoto Ito, Takahiro Aoyama, Hiroyuki Tachibana, Natsuo Tomita, Chiyoko Makita, Hiroshi Tanaka, Yutaro Koide, Tohru Iwata and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Hidetoshi ShimizuDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Koji SasakiGraduate School of Radiological Technology, Gunma Prefectural College of Health Sciences, Maebashi, Gunma, Japan.
Makoto ItoDepartment of Radiology, Aichi Medical University Hospital, Nagakute, Aichi, Japan.
Takahiro AoyamaDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Hiroyuki TachibanaDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Natsuo TomitaDepartment of Radiology, Nagoya City University Hospital, Nagoya, Aichi, Japan.
Chiyoko MakitaDepartment of Radiation Oncology, Gifu Prefectural General Medical Center, Gifu City, Gifu, Japan.
Hiroshi TanakaDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Yutaro KoideDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Tohru IwataDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Takeshi KodairaDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Aichi Cancer Center · JPAichi Medical University Hospital · JPGifu Prefectural General Medical Center · JPGunma Prefectural College of Health Sciences · JPNagoya City University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Helical tomotherapy (HT) can restrict beamlets passing through the virtual contour on computed tomography (CT) image in dose optimization, reducing the dose to organs at risk (OARs). Beamlet restriction limits the incident beamlet angles; thus, the proper planning target volume (PTV) margin may differ from that of the standard treatment plan without beamlet restriction, depending on the patient's movement during dose delivery. Dose distribution changes resulting from patient movement have not been described for treatment plans with beamlet restriction. This study quantified changes in dose distribution to the target and OARs when beamlet restriction is applied to cervical esophageal cancer treatment plan using HT by systematically shifting a phantom. Treatment plans for cervical esophageal cancers with and without beamlet restriction modes [directional block (DB) and nonblock (NB), respectively] were designed for CT images of the RANDO phantom. The PTV margin for the DB mode was set to be the same as that for the NB mode (5 mm). The CT image was intentionally shifted by ±1, ±2, and ±3 voxels in the left-right, anterior-posterior, and superior-inferior directions, and the dose distribution was recalculated for each position using the fluence for the NB or DB mode. When the phantom shift was within the same PTV margin as the NB mode, changes in doses to the targets, lungs, heart, and spinal cord in the DB mode were small as those in the NB mode. In conclusion, the virtual contour shape used in this study would provide safe delivery even with patient movement within the same PTV margin as for the NB mode.

Indexed as

Phantoms, ImagingEsophageal NeoplasmsHumansImage Processing, Computer-AssistedRadiometryRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedTomography, X-Ray Computeddirectional blockesophageal cancerhelical tomotherapypatient movement

Identifiers

PMID30997729
PMCPMC6523256
OpenAlexW2936939127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.